What's New at CBER You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA) This following links have been updated recently: Posted: 05/28/2021 Model Informed Drug Development Approaches for Immunogenicity Assessments Model Informed Drug Development Approaches for Immunogenicity Assessments Agenda

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA